Clinical Trial: Post COVID-19 Syndrome Treatment with Variable Pulse Transcranial Magnetic Stimulation

U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06865222) titled 'Post COVID-19 Syndrome Treatment with Variable Pulse Transcranial Magnetic Stimulation' on Feb. 25.

Brief Summary: The purpose of this study is to test if Variable Pulse TMS (Transcranial Magnetic Stimulation) can result in objective improvements in patients with Post COVID Syndrome (PCS).

Study Start Date: April, 2025

Study Type: INTERVENTIONAL

Condition: Post COVID-19 Condition

Intervention: PROCEDURE: Electromagnetic Brain Pulsing Variable Pulse Protocol (EMBP) - 2 weeks

The Electromagnetic Brain Pulsing Variable Pulse Protocol (EMBP) will be administered through an FDA-approved Transcranial Magnetic Stimulation (TMS) medi...